Camrelizumab In Advanced Or Metastatic Solid Tumor Patients With Microsatellite Instability-High/Mismatch Repair-Deficient: Results From An Open-Label Exploratory Study.

Jingde Chen,Ming Quan,Zhiqin Chen,Tianmei Zeng,Yandong Li,Ying Zhou,Yanan Hai,Yong Gao

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 0|浏览3

暂无评分

摘要

e15140Background: PD-1 checkpoint inhibitor has been shown a significant effect in patients (pts) with microsatellite instability-high (MSI-H) or mismatch repair-deficient (dMMR) solid tumor. Herei...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要